Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

NCT00758784 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: bromfenac ophthalmic solution 0.06%

Sponsor

Bausch & Lomb Incorporated